Filitra 20 mg is a medication that contains Vardenafil, a PDE5 inhibitor similar to Sildenafil (Viagra) and Tadalafil (Cialis). It is primarily used for the treatment of erectile dysfunction (ED) by enhancing blood flow to the *****. To understand how Filitra 20 mg works, we need to break down its effects in the body, particularly where and how it exerts its action. Where Does Filitra 20 mg Work in the Body? The main site of action for Filitra 20 mg is the blood vessels and smooth muscle tissue in the *****, but it also has systemic effects in the cardiovascular system. Here’s a closer look at its action: 1. In the ***** (Primary Site of Action) PDE5 Inhibition: Like other PDE5 inhibitors, Filitra 20 mg works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which is found in the smooth muscle tissue of the *****. PDE5 breaks down a substance called cGMP, which is responsible for the relaxation of smooth muscle and dilation of blood vessels in the *****. Increased Blood Flow: By inhibiting PDE5, Filitra 20 mg increases the levels of cGMP, which allows for the relaxation of smooth muscle cells in the penile blood vessels. This leads to widening (vasodilation) of the blood vessels in the *****, increasing blood flow and leading to an erection when a man is *****ly aroused. Erection: The increased blood flow to the ***** helps achieve and maintain an erection, making Filitra 20 mg effective in treating erectile dysfunction (ED). However, ***** stimulation is still required for the medication to work—it doesn’t cause an erection on its own. 2. In the Cardiovascular System (Secondary Action) Systemic Vasodilation: While Filitra 20 mg is targeted mainly at the *****, the effects of PDE5 inhibition are not limited to just the penile tissue. The relaxation of smooth muscle caused by increased cGMP can affect blood vessels throughout the body, leading to some systemic vasodilation (widening of blood vessels). Blood Pressure: This can cause a slight decrease in blood pressure in some individuals, although this is usually mild and not typically dangerous for healthy individuals. However, people with low blood pressure or those taking other medications that affect blood pressure should use Filitra 20 mg with caution and under the guidance of a doctor. 3. In the Lungs (Minimal Effect) Pulmonary Arterial Hypertension (PAH): Although not its primary indication, Vardenafil (the active ingredient in Filitra 20 mg) has been shown to have some benefits in treating pulmonary arterial hypertension (PAH), a condition in which the blood pressure in the lungs is abnormally high. Vasodilation in the Lungs: In this case, Filitra helps to dilate the blood vessels in the lungs, reducing the resistance in the pulmonary arteries and making it easier for the heart to pump blood through the lungs. However, for PAH, higher doses of Vardenafil are usually required, and Filitra 20 mg is typically used for ED, not PAH. 4. In the Liver and Kidneys (Metabolism and Elimination) Metabolism: Filitra 20 mg is absorbed into the bloodstream and metabolized primarily by the liver. It’s broken down by the CYP3A4 enzyme (part of the cytochrome P450 system), which is responsible for metabolizing many medications. Excretion: After it’s metabolized, Filitra is then excreted through the urine. The half-life of Vardenafil (Filitra’s active ingredient) is around 4 to 5 hours, meaning the drug remains active in the body for several hours after administration.